![Yasunari Kashihara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yasunari Kashihara
Direktor/Vorstandsmitglied bei
ONCOLYS BIOPHARMA INC.
Vermögen: 4 Mio $ am 31.08.2026
Profil
Yasunari Kashihara is Managing Director & Head-Business Development at Oncolys BioPharma, Inc. since 2024.
Director at Unleash Immuno Oncolytics, Inc. since 2018.
Director at Oncolys USA, Inc. since 2020.
President at Liquid Biotech USA, Inc. since 2017.
Formerly President & Chief Executive Officer at UMN Pharma, Inc. Director at Precision Virologics, Inc. Licensing Manager at Santen Pharmaceutical Co., Ltd. Pharmacological Researcher at Nihon Ciba-Geigy KK.
Education includes an MBA from Trinity College Dublin (2002), undergraduate and graduate degrees from Kyoto University, a graduate degree from Kyoto Pharmaceutical University (1991), and an undergraduate degree from Osaka Prefectural Semboku High School (1984).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCOLYS BIOPHARMA, INC. 0,45 % | 31.12.2025 | 133.000 ( 0,45 % ) | 4 Mio $ | 31.08.2026 |
Aktive Positionen von Yasunari Kashihara
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOLYS BIOPHARMA INC. | Direktor/Vorstandsmitglied | 01.03.2008 |
Liquid Biotech USA, Inc.
 Liquid Biotech USA, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnosing services | Präsident | 01.11.2017 |
Unleash Immuno Oncolytics, Inc.
 Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Develops oncolytic virus immunotherapy products to treat cancer | Direktor/Vorstandsmitglied | 01.02.2018 |
Oncolys USA, Inc.
 Oncolys USA, Inc. Pharmaceuticals: OtherHealth Technology Part of Oncolys BioPharma, Inc., Oncolys USA, Inc. is a company based in Fort Lee, NJ. | Direktor/Vorstandsmitglied | 01.01.2020 |
Ehemalige bekannte Positionen von Yasunari Kashihara
| Unternehmen | Position | Ende |
|---|---|---|
Precision Virologics, Inc.
 Precision Virologics, Inc. BiotechnologyHealth Technology Researches and develops emerging infectious disease vaccines based on genetically modified adenovirus | Direktor/Vorstandsmitglied | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| UMN PHARMA INC. | Präsident | - |
Ausbildung von Yasunari Kashihara
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Santen Pharmaceutical Co., Ltd.
 Santen Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales prescription drugs & medical devices to treat ophthalmology diseases | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyoto University
 Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UMN Pharma, Inc.
 UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Kyoto Pharmaceutical University
 Kyoto Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncolys BioPharma, Inc.
 Oncolys BioPharma, Inc. BiotechnologyHealth Technology Engages in the research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents | Health Technology |
Osaka Prefectural Semboku High School
 Osaka Prefectural Semboku High School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Develops oncolytic virus immunotherapy products to treat cancer | Health Technology |
Precision Virologics, Inc.
Precision Virologics, Inc. BiotechnologyHealth Technology Researches and develops emerging infectious disease vaccines based on genetically modified adenovirus | Health Technology |
Liquid Biotech USA, Inc.
Liquid Biotech USA, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnosing services | Health Services |
Oncolys USA, Inc.
Oncolys USA, Inc. Pharmaceuticals: OtherHealth Technology Part of Oncolys BioPharma, Inc., Oncolys USA, Inc. is a company based in Fort Lee, NJ. | Health Technology |
